Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
3 Ιαν 2023 · This statement from the International Antiviral Society–USA updates recommendations for the use of antiretroviral drugs to treat adults with established HIV infection and to prevent HIV infection among persons at risk.
3 Ιαν 2023 · Options for preexposure prophylaxis include oral medications (tenofovir disoproxil fumarate or tenofovir alafenamide plus emtricitabine) and, for the first time, a long-acting injectable agent, cabotegravir.
24 Ιουλ 2024 · A twice-yearly PrEP choice could overcome challenges with respect to adherence and persistence and result in substantial protection against HIV infection for women worldwide.
21 Ιουν 2023 · The new generation of long-acting or extended-release antiretroviral drugs, including long-acting broadly neutralizing monoclonal antibodies, has great promise for advancing biomedical HIV ...
5 Αυγ 2022 · Cabotegravir is the latest WHO-recommended drug that protects against HIV infection. In January 2021, the agency approved the use of a vaginal ring coated with the anti-HIV drug dapivirine. And...
11 Δεκ 2023 · Using drug therapy to block transmission and prevent HIV, HIV pre-exposure prophylaxis (PrEP) provides a critical intervention to reduce community spread and protect those with reasons to utilize PrEP.
